In this work, we show that the determination of the anticytomegalovirus antibody avidity carried out before week 18 of gestation is a helpful tool to identify women for enrollment in prenatal diagnosis. This procedure can identify all pregnant women who will give birth to an infected newborn.
Lazzarotto T, S.P. (1999). Anticytomegalovirus (Anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 6(1), 127-129 [10.1128/cdli.6.1.127-129.1999].
Anticytomegalovirus (Anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection
Lazzarotto T;Varani S;Guerra Brunella;Landini MP
1999
Abstract
In this work, we show that the determination of the anticytomegalovirus antibody avidity carried out before week 18 of gestation is a helpful tool to identify women for enrollment in prenatal diagnosis. This procedure can identify all pregnant women who will give birth to an infected newborn.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
